annual current liabilities:
$187.47M+$94.30M(+101.21%)Summary
- As of today (September 18, 2025), RXRX annual total current liabilities is $187.47 million, with the most recent change of +$94.30 million (+101.21%) on December 31, 2024.
- During the last 3 years, RXRX annual current liabilities has risen by +$140.81 million (+301.80%).
- RXRX annual current liabilities is now at all-time high.
Performance
RXRX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$164.03M+$22.05M(+15.53%)Summary
- As of today (September 18, 2025), RXRX quarterly total current liabilities is $164.03 million, with the most recent change of +$22.05 million (+15.53%) on June 30, 2025.
- Over the past year, RXRX quarterly current liabilities has increased by +$77.94 million (+90.54%).
- RXRX quarterly current liabilities is now -12.51% below its all-time high of $187.47 million, reached on December 31, 2024.
Performance
RXRX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RXRX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +101.2% | +90.5% |
| 3 y3 years | +301.8% | +69.7% |
| 5 y5 years | +2704.8% | - |
RXRX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +301.8% | -12.5% | +121.9% |
| 5 y | 5-year | at high | +2704.8% | -12.5% | +610.1% |
| alltime | all time | at high | +2704.8% | -12.5% | +610.1% |
RXRX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $164.03M(+15.5%) |
| Mar 2025 | - | $141.98M(-24.3%) |
| Dec 2024 | $187.47M(+101.2%) | $187.47M(+72.2%) |
| Sep 2024 | - | $108.89M(+26.5%) |
| Jun 2024 | - | $86.08M(+16.5%) |
| Mar 2024 | - | $73.92M(-20.7%) |
| Dec 2023 | $93.17M(-7.1%) | $93.17M(-1.0%) |
| Sep 2023 | - | $94.12M(-17.4%) |
| Jun 2023 | - | $113.96M(+23.7%) |
| Mar 2023 | - | $92.15M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $100.27M(+114.9%) | $100.27M(+20.7%) |
| Sep 2022 | - | $83.04M(-14.1%) |
| Jun 2022 | - | $96.65M(+12.8%) |
| Mar 2022 | - | $85.70M(+83.7%) |
| Dec 2021 | $46.66M(+102.0%) | $46.66M(+8.7%) |
| Sep 2021 | - | $42.94M(+45.4%) |
| Jun 2021 | - | $29.54M(+10.0%) |
| Mar 2021 | - | $26.85M(+16.3%) |
| Dec 2020 | $23.10M(+245.6%) | - |
| Dec 2020 | - | $23.10M |
| Dec 2019 | $6.68M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual total current liabilities?
The current annual current liabilities of RXRX is $187.47M
What is the all time high annual current liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual total current liabilities is $187.47M
What is Recursion Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, RXRX annual total current liabilities has changed by +$94.30M (+101.21%)
What is Recursion Pharmaceuticals, Inc. quarterly total current liabilities?
The current quarterly current liabilities of RXRX is $164.03M
What is the all time high quarterly current liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly total current liabilities is $187.47M
What is Recursion Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, RXRX quarterly total current liabilities has changed by +$77.94M (+90.54%)